NCT02089399View on ClinicalTrials.gov

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Sevikar(amlodipne/olmesartan)

Treatment AB

DRUG

crestor(Rosuvastatin)

Treatment AB/Treatment C

Trial Locations (1)

Unknown

Samsung medical center, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT02089399 - Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter